Müller (German trade company) then opened another 86 outlets by 1990. Since then the company has expanded in Europe. Müller has more than 34,000 employees. In 2010 the company earned revenues of 2.42 billion Euro. Erwin Müller and Elke Menold are General Managers of the company. In 2004, the company was transformed into a Limited & Co. KG (a hybrid of the English cognate of the German GmbH and the German word "Compagnie Kommanditgesellschaft", meaning "limited partnership") when the company registered under English law in London. By October 2017 Müller had a total of 812 outlets in 7 European countries: Müller is primarily a
Fresenius (company) of a majority stake of Humaine Kliniken. HUMAINE operates six acute and post acute care hospitals in the fields of neurology, oncology and traumatology On July 16, 2007, the company completed its conversion from an Aktiengesellschaft (AG - German public limited company) to a Societas Europaea, the European Union-wide equivalent. The company changed its legal status once again on January 28, 2011, becoming a Kommanditgesellschaft auf Aktien (KGaA - German partnership limited by shares) with a "Societas Europaea" as a partner with unlimited liability (SE & Co. KGaA). In August 2008 Fresenius Kabi acquired Dabur Pharma Ltd by acquiring 73.3%